Overcoming Resistance to the First Generation of G12C Inhibitors to Increase Patient Response Rates

Time: 11:00 am
day: Day One Track B AM


  • Assessing the observed resistance mechanisms against G12C inhibitors in the clinic and beyond
  • Creating actionable insights to overcome resistance and increase the effectiveness of RAS therapies
  • Devising strategies from the current learnings to improve patient response to RAS drugs in future trials